Evaluation of VTE prophylaxis and the impact of alternate regimens on post-operative bleeding and thrombotic complications following bariatric procedures
- PMID: 29766305
- DOI: 10.1007/s00464-018-6231-z
Evaluation of VTE prophylaxis and the impact of alternate regimens on post-operative bleeding and thrombotic complications following bariatric procedures
Abstract
Background: Studies examining utilization and impact of venous thromboembolism (VTE) chemoprophylaxis for patients undergoing bariatric surgery are limited. Determination of the optimal prophylactic regimen to minimize complications is crucial.
Methods: The Cerner Health Facts database from 2003 to 2013 was queried using ICD-9 codes to identify patients undergoing laparoscopic sleeve gastrectomy (LSG) and Roux-en-Y gastric bypass (RYGB). VTE chemoprophylaxis regimens were divided into pre-operative alone (PreP), post-operative alone (PostP), both pre-operative and post-operative (PPP), or no prophylaxis (NP). Specific chemoprophylaxis agents were compared. Comparisons in inpatient clinical outcomes were based on univariate analysis and multivariable logistic regression when appropriate.
Results: We identified 11,860 patients who underwent LSG and RYGB. 634 (5.35%) had PreP, 4593 (38.73%) had PostP, 2646 (22.31%) had PPP, and 3987 (33.62%) had NP. The overall rates of transfusion, DVT, and PE were 2.48, 0.27, and 0.18%, respectively. Patients without chemoprophylaxis had higher rate of DVT compared to any chemoprophylaxis (0.58 vs 0.11%, p < 0.0001), without any significant difference in PE rate. Patients with pre-operative chemoprophylaxis were more likely to receive transfusion compared to patients with post-operative prophylaxis alone (OR 1.98, 95% CI 1.28-3), without significant difference in having VTE. When examining heparin versus enoxaparin versus mixed regimen in the PostP group, mixed regimen was associated with increased transfusion requirements (p < 0.001).
Conclusions: Bariatric surgical VTE chemoprophylaxis utilization is inconsistent. In this study, post-operative VTE chemoprophylaxis was associated with decreased VTE events compared to NP, while minimizing bleeding compared to PreP. Mixed therapy using heparin and enoxaparin was associated with more bleeding.
Keywords: Bariatric surgery; VTE events.
Similar articles
-
Increased bleeding risk with enoxaparin venothromboembolism prophylaxis compared with heparin in patients undergoing bariatric surgery.Surg Endosc. 2023 Sep;37(9):6983-6988. doi: 10.1007/s00464-023-10219-2. Epub 2023 Jun 21. Surg Endosc. 2023. PMID: 37344753
-
Venous thromboembolism risk for the contemporary bariatric surgeon.Surg Endosc. 2020 Aug;34(8):3521-3526. doi: 10.1007/s00464-019-07134-w. Epub 2019 Sep 26. Surg Endosc. 2020. PMID: 31559578
-
High Risk of Symptomatic Venous Thromboembolism After Surgery for Spine Metastatic Bone Lesions: A Retrospective Study.Clin Orthop Relat Res. 2019 Jul;477(7):1674-1686. doi: 10.1097/CORR.0000000000000733. Clin Orthop Relat Res. 2019. PMID: 31135550 Free PMC article.
-
Ximelagatran/Melagatran: a review of its use in the prevention of venous thromboembolism in orthopaedic surgery.Drugs. 2004;64(6):649-78. doi: 10.2165/00003495-200464060-00010. Drugs. 2004. PMID: 15018597 Review.
-
Venous thromboembolism after laparoscopic bariatric surgery for morbid obesity: clinical burden and prevention.Surg Obes Relat Dis. 2012 Jan-Feb;8(1):108-15. doi: 10.1016/j.soard.2011.09.005. Epub 2011 Sep 16. Surg Obes Relat Dis. 2012. PMID: 22014482 Review.
Cited by
-
Cumulative Incidence of Venous Thromboembolic Events In-Hospital, and at 1, 3, 6, and 12 Months After Metabolic and Bariatric Surgery: Systematic Review of 87 Studies and Meta-analysis of 2,731,797 Patients.Obes Surg. 2024 Jun;34(6):2154-2176. doi: 10.1007/s11695-024-07184-7. Epub 2024 Apr 11. Obes Surg. 2024. PMID: 38602603 Free PMC article. Review.
-
The use of enoxaparin as venous thromboembolism prophylaxis in bariatric surgery: A retrospective cohort study.Saudi Pharm J. 2022 Oct;30(10):1473-1478. doi: 10.1016/j.jsps.2022.07.008. Epub 2022 Jul 22. Saudi Pharm J. 2022. PMID: 36387338 Free PMC article.
-
Postoperative Timing of Chemoprophylaxis and Its Impact on Thromboembolism and Bleeding Following Major Abdominal Surgery: A Multicenter Cohort Study.World J Surg. 2023 May;47(5):1174-1183. doi: 10.1007/s00268-023-06899-5. Epub 2023 Feb 18. World J Surg. 2023. PMID: 36806555 Free PMC article.
-
Early Versus Postoperative Chemical Thromboprophylaxis Is Associated with Increased Bleeding Risk Following Abdominal Visceral Resections: a Multicenter Cohort Study.J Gastrointest Surg. 2022 Jul;26(7):1495-1502. doi: 10.1007/s11605-022-05301-4. Epub 2022 Mar 22. J Gastrointest Surg. 2022. PMID: 35318594 Free PMC article.
-
Enhanced recovery after bariatric surgery: an Italian consensus statement.Surg Endosc. 2022 Oct;36(10):7171-7186. doi: 10.1007/s00464-022-09498-y. Epub 2022 Aug 11. Surg Endosc. 2022. PMID: 35953683 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous